Skip to content
Riskpilot
← Back to search
Sign in
Get full access
FB biotech AB
AB
Active
Org 5568727159
Kullsviksvägen 23, 429 35
Kullavik
Business and other management consultancy activities
· NACE 7020
Est. 2011
0 employees
Watchlist
Share
Sweden
/
Companies
/
Business and other management consultancy activities
/
FB biotech AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
-1M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
0
—
0
0
192
Staff expenses
—
—
—
—
−1
EBITDA
−959
−175
−169
−58
36
Depreciation & amort.
−0
—
—
—
—
EBIT
−959
−175
−169
−58
36
Net financials
6 776
282
745
22
−0
Profit before tax
6 955
107
576
−36
36
Tax
−166
−161
−136
—
—
Net profit
6 789
−54
440
−36
36
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
21 871
18 566
18 919
384
379
Equity
21 657
18 376
18 621
258
355
Long-term debt
0
—
—
—
—
Short-term debt
214
190
299
126
23
Total debt
214
190
299
126
23
Financial ratios
5-year trend
EBITDA margin
18.9%
This company
15.8%
Market median
+20% vs market
2021
2025
Equity ratio
93.8%
This company
38.2%
Market median
+146% vs market
2021
2025
Return on equity
10.2%
This company
18.4%
Market median
+45% vs market
2021
2025
Net profit margin
18.9%
This company
8.1%
Market median
+133% vs market
2021
2025
Asset turnover
0.51×
This company
1.12×
Market median
-54% vs market
2021
2025
Debt / equity
0.07×
This company
0.62×
Market median
+89% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on FB biotech AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
